{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:42:35Z","timestamp":1740116555220,"version":"3.37.3"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.diabres.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T12:23:32Z","timestamp":1462019012000},"page":"26-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?"],"prefix":"10.1016","volume":"116","author":[{"given":"J.F.","family":"Gautier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Monguillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Verier-Mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Fiquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dejager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Charbonnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2016.04.008_b0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1463-1326.2012.01613.x","article-title":"Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes","volume":"14","author":"Freemantle","year":"2012","journal-title":"Diab Obes Metab"},{"issue":"41","key":"10.1016\/j.diabres.2016.04.008_b0010","first-page":"93","article-title":"Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?","volume":"2013","author":"Charbonnel","year":"1995","journal-title":"Hosp Pract"},{"key":"10.1016\/j.diabres.2016.04.008_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e1771","article-title":"Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses","volume":"344","author":"Hemmingsen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2016.04.008_b0020","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diab Care"},{"key":"10.1016\/j.diabres.2016.04.008_b0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/dmrr.1288","article-title":"Strategies for insulin initiation: insights from the French LIGHT observational study","volume":"28","author":"Verges","year":"2012","journal-title":"Diab Metab Res Rev"},{"key":"10.1016\/j.diabres.2016.04.008_b0030","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1463-1326.2011.01412.x","article-title":"An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia","volume":"13","author":"Fonseca","year":"2011","journal-title":"Diab Obes Metab"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716300729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716300729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T12:14:12Z","timestamp":1656245652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822716300729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":6,"alternative-id":["S0168822716300729"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.04.008","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which oral antidiabetic drug to combine with metformin to minimize the risk of hypoglycemia when initiating basal insulin?","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}